Helixmith Co Ltd - ESG Rating & Company Profile powered by AI
Full ESG analysis of Helixmith Co Ltd are accessed by signing in. Jump to the bottom of this page for potential risks for Helixmith Co Ltd based on sector, location and marketcap. The Sustainability rating for Helixmith Co Ltd represents the company's reporting of the UN Sustainable Development Goals.
Helixmith Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.0; made up of an environmental score of 3.2, social score of 1.6 and governance score of 1.3.
2.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2110 | Yabao Pharmaceutical Group Co Ltd | 2.1 | Medium |
| 2110 | scPharmaceuticals Inc | 2.1 | Medium |
| 2150 | Helixmith Co Ltd | 2.0 | Medium |
| 2150 | BNC Korea Co Ltd | 2.0 | Medium |
| 2150 | BTG Ltd | 2.0 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Helixmith Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Helixmith Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Helixmith Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Helixmith Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Helixmith Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Helixmith Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Helixmith Co Ltd offer flexible work?
Sign up for free to unlockDoes Helixmith Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Helixmith Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Helixmith Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Helixmith Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Helixmith Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Helixmith Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Helixmith Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Helixmith Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Helixmith Co Ltd disclose water use targets?
Sign up for free to unlockDoes Helixmith Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Helixmith Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Helixmith Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Helixmith Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Helixmith Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Helixmith Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Helixmith Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Helixmith Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Helixmith Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Helixmith Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Helixmith Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Helixmith Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Helixmith Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Helixmith Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Helixmith Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Helixmith Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Helixmith Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Helixmith Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Helixmith Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Helixmith Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Helixmith Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological diseases. The company's pipeline products include VM206, a therapeutic cancer vaccine targeting HER2/neu positive breast or ovarian cancer; and VM501, a re-engineered form of interleukin 11 targeting chemotherapy-induced thrombocytopenia. Its clinical trials biologics comprise VM202-DPN, VM202-PAD, VM501, VM202-ALS, VM202-CAD, and VM206. The company was formerly known as ViroMed Co., Ltd. and changed its name to Helixmith Co., Ltd in April 2019. Helixmith Co., Ltd was incorporated in 1996 and is headquartered in Seoul, South Korea.